Skip to main content

Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp.

Introduction

Low IgA levels in blood serum and in saliva have been associated with an increased risk for Candida colonization and infection [1, 2]. In this retrospective cohort study, we aimed to evaluate the effects of an intravenous immunoglobulin preparation containing polyclonal IgG, IgM and IgA (IgGAM) on the prevention of Candida spp. colonization in patients with septic shock.

Methods

In this study we analyzed 69 patients with septic shock and without Candida spp. colonization before shock appearance admitted to the ICU of a university hospital from January 2008 to November 2011. All of the patients were treated in according to the Surviving Sepsis Campaign guidelines. In addition to standard therapy, 44 (64%) patients received IgGAM therapy (Pentaglobin® 38 g/l IgG, 6 g/l IgM, and 6 g/l IgA) within 24 hours from the diagnosis of septic shock at the dose of 250 mg/kg/day for 3 days. The colonization by Candida spp. was evaluated by analyzing the results of the microbiological surveillance cultures (two times per week) of pharyngeal swab, tracheal aspirate, urine and surgical drains between 48 hours and 21 days after the diagnosis of septic shock.

Results

In the IgGAM group, 11 patients (25%) developed Candida spp. colonization compared to nine patients (36%) of the control group. The Candida colonization index was similar in the two groups: 0.42 ± 0.16 in the IgGAM group and 0.45 in the control group.

Conclusion

The above data show a slight reduction of Candida spp. colonization in septic shock patients treated with IgGAM therapy. Further studies are needed to confirm this finding.

References

  1. 1.

    Gonçalves e Silva CR, Melo KE, Leão MV, Ruis R, Jorge AO: Relationship between Candida in vaginal and oral mucosae and salivary IgA. Rev Bras Ginecol Obstet 2008, 30: 300-305. 10.1590/S0100-72032008000600006

    Article  PubMed  Google Scholar 

  2. 2.

    Bai XD, Liu XH, Tong QY: Intestinal colonization with Candida albicans and mucosal immunity. World J Gastroenterol 2004, 10: 2124-2126.

    PubMed Central  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to G Serafini.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Serafini, G., Cavazzuti, I., Venturelli, C. et al. Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp.. Crit Care 16, P48 (2012). https://doi.org/10.1186/cc10655

Download citation

Keywords

  • Septic Shock
  • Septic Shock Patient
  • Survive Sepsis Campaign
  • Tracheal Aspirate
  • Surveillance Culture